Schmunk GA - Search Results

1

Brain serotonin transporter in human methamphetamine users.

Kish SJ, Fitzmaurice PS, Boileau I, Schmunk GA, Ang LC, Furukawa Y, Chang LJ, Wickham DJ, Sherwin A, Tong J. Kish SJ, et al. Among authors: schmunk ga. Psychopharmacology (Berl). 2009 Mar;202(4):649-61. doi: 10.1007/s00213-008-1346-x. Epub 2008 Oct 8. Psychopharmacology (Berl). 2009. PMID: 18841348

2

Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users.

Tong J, Ross BM, Schmunk GA, Peretti FJ, Kalasinsky KS, Furukawa Y, Ang LC, Aiken SS, Wickham DJ, Kish SJ. Tong J, et al. Among authors: schmunk ga. Am J Psychiatry. 2003 May;160(5):896-903. doi: 10.1176/appi.ajp.160.5.896. Am J Psychiatry. 2003. PMID: 12727693

3

Why is parkinsonism not a feature of human methamphetamine users?

Moszczynska A, Fitzmaurice P, Ang L, Kalasinsky KS, Schmunk GA, Peretti FJ, Aiken SS, Wickham DJ, Kish SJ. Moszczynska A, et al. Among authors: schmunk ga. Brain. 2004 Feb;127(Pt 2):363-70. doi: 10.1093/brain/awh046. Epub 2003 Nov 25. Brain. 2004. PMID: 14645148

4

Is brain gliosis a characteristic of chronic methamphetamine use in the human?

Tong J, Fitzmaurice P, Furukawa Y, Schmunk GA, Wickham DJ, Ang LC, Sherwin A, McCluskey T, Boileau I, Kish SJ. Tong J, et al. Among authors: schmunk ga. Neurobiol Dis. 2014 Jul;67:107-18. doi: 10.1016/j.nbd.2014.03.015. Epub 2014 Apr 2. Neurobiol Dis. 2014. PMID: 24704312

5

The human nucleus accumbens is highly susceptible to G protein down-regulation by methamphetamine and heroin.

McLeman ER, Warsh JJ, Ang L, Li PP, Kalasinsky KS, Ross BM, Tong J, Schmunk G, Adams V, Kish SJ. McLeman ER, et al. J Neurochem. 2000 May;74(5):2120-6. doi: 10.1046/j.1471-4159.2000.0742120.x. J Neurochem. 2000. PMID: 10800957 Free article.

6

Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users.

Worsley JN, Moszczynska A, Falardeau P, Kalasinsky KS, Schmunk G, Guttman M, Furukawa Y, Ang L, Adams V, Reiber G, Anthony RA, Wickham D, Kish SJ. Worsley JN, et al. Mol Psychiatry. 2000 Nov;5(6):664-72. doi: 10.1038/sj.mp.4000760. Mol Psychiatry. 2000. PMID: 11126397

7

Striatal dopaminergic and serotonergic markers in human heroin users.

Kish SJ, Kalasinsky KS, Derkach P, Schmunk GA, Guttman M, Ang L, Adams V, Furukawa Y, Haycock JW. Kish SJ, et al. Among authors: schmunk ga. Neuropsychopharmacology. 2001 May;24(5):561-7. doi: 10.1016/S0893-133X(00)00209-8. Neuropsychopharmacology. 2001. PMID: 11282256

8

Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine.

Ross BM, Moszczynska A, Peretti FJ, Adams V, Schmunk GA, Kalasinsky KS, Ang L, Mamalias N, Turenne SD, Kish SJ. Ross BM, et al. Among authors: schmunk ga. Drug Alcohol Depend. 2002 Jun 1;67(1):73-9. doi: 10.1016/s0376-8716(02)00022-4. Drug Alcohol Depend. 2002. PMID: 12062780

9

Dopaminergic changes in human brain following acute exposure to gamma-hydroxybutyrate.

Kish SJ, Kalasinsky KS, Schmunk G, Furukawa Y, Guttman M, Ang L. Kish SJ, et al. Neurology. 2001 Jun 12;56(11):1602-3. doi: 10.1212/wnl.56.11.1602. Neurology. 2001. PMID: 11402130 No abstract available.

10

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users.

Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ. Wilson JM, et al. Among authors: schmunk ga. Nat Med. 1996 Jun;2(6):699-703. doi: 10.1038/nm0696-699. Nat Med. 1996. PMID: 8640565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters